TWD 49.25
(-9.96%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 63.9 Million TWD | 88.68% |
2022 | 33.86 Million TWD | 16.05% |
2021 | 29.18 Million TWD | 6.17% |
2020 | 27.48 Million TWD | 20.05% |
2019 | 22.89 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 20.38 Million TWD | -6.77% |
2024 Q1 | 21.86 Million TWD | 25.89% |
2023 Q4 | 17.36 Million TWD | -2.21% |
2023 Q3 | 17.75 Million TWD | 14.66% |
2023 FY | 63.9 Million TWD | 88.68% |
2023 Q2 | 15.48 Million TWD | 16.54% |
2023 Q1 | 13.29 Million TWD | 30104.55% |
2022 Q4 | 44 Thousand TWD | 0.0% |
2022 FY | 33.86 Million TWD | 16.05% |
2021 FY | 29.18 Million TWD | 6.17% |
2020 FY | 27.48 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -19323.404% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 49.947% |
Level Biotechnology Inc. | 151.99 Million TWD | 57.957% |
Sagittarius Life Science Corp | 135.85 Million TWD | 52.962% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 15.761% |
TaiMed Biologics Inc. | 225.23 Million TWD | 71.628% |
GlycoNex Incorporation | 995 Thousand TWD | -6322.412% |
VBI | 32.55 Million TWD | -96.292% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 75.122% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 67.092% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -38.85% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 46.708% |
Visgeneer Inc. | 67.48 Million TWD | 5.304% |
Mycenax Biotech Inc. | -375.19 Million TWD | 117.032% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 87.472% |
Neith Corporation | 66.87 Million TWD | 4.441% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 95.575% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -117.713% |
Enimmune corporation | 220.1 Million TWD | 70.967% |
TaiRx, Inc. | 217.13 Million TWD | 70.57% |
CHO Pharma, Inc. | 268.99 Million TWD | 76.244% |
EirGenix Inc. | 236.74 Million TWD | 73.007% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 38.761% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 82.131% |
Lin BioScience, Inc. | 1.09 Billion TWD | 94.174% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 75.991% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -29.173% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -5800.554% |
Lukas Biomedical Inc. | 177.45 Million TWD | 63.988% |
RBC Bioscience Corporation | 58.35 Million TWD | -9.505% |
BiOptic Inc. | 108.69 Million TWD | 41.207% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -70903.333% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 7.854% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -2343.709% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 90.076% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 31.534% |
NaviFUS Corp. | 11.82 Million TWD | -440.315% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 66.495% |
Sinew Pharma Inc. | 186.25 Million TWD | 65.69% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 13.671% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 71.006% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -54.054% |
AP Biosciences Inc | 32.25 Million TWD | -98.13% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 96.547% |
3D Global Biotech Inc. | 5.27 Million TWD | -1111.661% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 79.862% |
Intech Biopharm Corporation | -163.99 Million TWD | 138.966% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 94.341% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -54.05% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 62.312% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 56.535% |
TCI GENE Inc. | 174.61 Million TWD | 63.404% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -354916.667% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 78.765% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 78.037% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 23.875% |
PharmaEngine, Inc. | 441.78 Million TWD | 85.535% |
Savior Lifetec Corporation | 223.36 Million TWD | 71.391% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 75.306% |
OBI Pharma, Inc. | 2.01 Billion TWD | 96.831% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 53.984% |
Acepodia, Inc. | 452.56 Million TWD | 85.88% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 88.187% |